Interchangeability between SP263 and 22C3 assays in lung cancer specimens: a reality in daily practice

被引：0
|
作者：
Jang, Min Hye [1 ]
Baek, Jina [2 ]
Shin, Kyeong-Cheol [2 ]
Lee, Jang Hoon [2 ]
机构：
[1] Yeungnam Univ Hosp, Daegu, South Korea
[2] Yeungnam Univ, Sch Med, Daegu, South Korea
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1841
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression in Non-Small-Cell Lung Cancer Using Routine Clinical and Conditioned Archives
    Kim, Sue Youn
    Kim, Tae-Eun
    Park, Chan Kwon
    Yoon, Hyoung-Kyu
    Sa, Young Jo
    Kim, Hyo Rim
    Woo, In Sook
    Kim, Tae-Jung
    CANCERS, 2022, 14 (13)
  • [22] Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
    Marchetti, Antonio
    Barberis, Massimo
    Franco, Renato
    De Luca, Graziano
    Pace, Maria Vittoria
    Staibano, Stefania
    Volante, Marco
    Buttitta, Fiamma
    Guerini-Rocco, Elena
    Righi, Luisella
    D'antuono, Tommaso
    Scagliotti, Giorgio V.
    Pinto, Carmine
    De Rosa, Gaetano
    Papotti, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1654 - 1663
  • [23] PD-L1 status in Taiwanese lung adenocarcinoma patients: Comparison of PD-L1 immunohistochemical assays using antibody clones 22C3, SP142 and SP263 with clinicopathological correlation
    Yeh, Y-C.
    Lin, S-F.
    Chiu, C-H.
    Wu, Y-C.
    Hsieh, W-Y.
    Ho, H-L.
    Chou, T-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation-Positive Lung Adenocarcinoma
    Kim, Taehee
    Cha, Yoon Jin
    Chang, Yoon Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (01) : 51 - 60
  • [25] Expression of PD-L1 on Routine Non-Small Cell Lung Carcinoma Sections: Comparative Assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx)
    Quinn, A. M.
    Gosney, J.
    Bishop, P.
    Bloor, R.
    Harreld, C.
    Mcnulty, C.
    Bowden, R.
    Moss, A.
    Forrest, S.
    Montero, A.
    Chaturvedi, A.
    Joseph, L.
    Paiva-Correia, A.
    Doran, H.
    Taniere, P.
    Crosbie, P.
    Blackhall, F.
    Summers, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S761 - S763
  • [26] PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
    Park, Yujun
    Koh, Jiwon
    Na, Hee Young
    Kwak, Yoonjin
    Lee, Keun-Wook
    Ahn, Sang-Hoon
    Park, Do Joong
    Kim, Hyung-Ho
    Lee, Hye Seung
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 661 - 670
  • [27] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Cha, Yoon Jin
    Kim, Dooreh
    Bae, Soong June
    Ahn, Sung Gwe
    Jeong, Joon
    Lee, Hye Sun
    Jeon, Soyoung
    Yoo, Tae-Kyung
    Park, Woo-Chan
    Yoon, Chang Ik
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
    Yoon Jin Cha
    Dooreh Kim
    Soong June Bae
    Sung Gwe Ahn
    Joon Jeong
    Hye Sun Lee
    Soyoung Jeon
    Tae-Kyung Yoo
    Woo-Chan Park
    Chang Ik Yoon
    Scientific Reports, 11
  • [29] Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
    Zhou, Caicun
    Srivastava, Minu K.
    Xu, Hao
    Felip, Enriqueta
    Wakelee, Heather
    Altorki, Nasser
    Reck, Martin
    Liersch, Rudiger
    Kryzhanivska, Anna
    Oizumi, Satoshi
    Tanaka, Hiroshi
    Hamm, John
    McCune, Steven L.
    Bennett, Elizabeth
    Gitlitz, Barbara
    McNally, Virginia
    Ballinger, Marcus
    McCleland, Mark
    Zou, Wei
    Das Thakur, Meghna
    Novello, Silvia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [30] PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays
    Munari, Enrico
    Zamboni, Giuseppe
    Lunardi, Gianluigi
    Marconi, Marcella
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Quatrini, Linda
    Vacca, Paola
    Moretta, Lorenzo
    Bogina, Giuseppe
    HUMAN PATHOLOGY, 2019, 90 : 54 - 59
12345